Literature DB >> 20671726

High-throughput screening of tissue-nonspecific alkaline phosphatase for identification of effectors with diverse modes of action.

Eduard A Sergienko1, José Luis Millán.   

Abstract

Here we describe a protocol for the identification of effectors of tissue-nonspecific alkaline phosphatase (TNAP). It is based on a highly sensitive method for detecting TNAP activity. After dephosphorylation by TNAP, a dioxetane-based substrate undergoes a series of chemical transformations resulting in light production. Light intensity serves as a quantitative measure of the velocity of the TNAP-catalyzed reaction in the steady state. This protocol includes guidelines for optimizing the assay and for high-throughput screening in multiwell plates. The assay is sensitive to the influence of diverse effectors of TNAP as long as the assay optimization steps are repeated for each new batch of the enzyme; full optimization is accomplished in under 2 d. Depending on the available equipment, 10,000-100,000 compounds can be screened in an 8-h period. This protocol provides a method of screening TNAP that is 1,000-fold more sensitive and 10-fold faster than a conventional colorimetric assay with p-nitrophenyl phosphate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671726      PMCID: PMC3908691          DOI: 10.1038/nprot.2010.86

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  13 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  A model of the transition state in the alkaline phosphatase reaction.

Authors:  K M Holtz; B Stec; E R Kantrowitz
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

3.  Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia.

Authors:  K N Fedde; L Blair; J Silverstein; S P Coburn; L M Ryan; R S Weinstein; K Waymire; S Narisawa; J L Millán; G R MacGregor; M P Whyte
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

4.  Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans.

Authors:  H Van Belle
Journal:  Clin Chem       Date:  1976-07       Impact factor: 8.327

5.  Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta; L-phenylalanine, L-tryptophan and L homoarginine.

Authors:  W H Fishman; H G Sie
Journal:  Enzymologia       Date:  1971-09-30

6.  Human skeletal alkaline phosphatase. Kinetic studies including pH dependence and inhibition by theophylline.

Authors:  J R Farley; J L Ivey; D J Baylink
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

7.  Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase.

Authors:  M P Whyte; J D Mahuren; K N Fedde; F S Cole; E R McCabe; S P Coburn
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

8.  Kinetic parameters for the cleaved substrate, and enzyme and substrate stability, vary with the phosphoacceptor in alkaline phosphatase catalysis.

Authors:  R A Stinson
Journal:  Clin Chem       Date:  1993-11       Impact factor: 8.327

9.  Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).

Authors:  Russell Dahl; Eduard A Sergienko; Ying Su; Yalda S Mostofi; Li Yang; Ana Maria Simao; Sonoko Narisawa; Brock Brown; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H Smith; W Charles O'Neill; José Luis Millán; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

10.  Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).

Authors:  Shyama Sidique; Robert Ardecky; Ying Su; Sonoko Narisawa; Brock Brown; José Luis Millán; Eduard Sergienko; Nicholas D P Cosford
Journal:  Bioorg Med Chem Lett       Date:  2008-10-31       Impact factor: 2.823

View more
  10 in total

1.  Inhibition of ecto-ATPase activity by curcumin in hepatocellular carcinoma HepG2 cells.

Authors:  Takuto Fujii; Takuma Minagawa; Takahiro Shimizu; Noriaki Takeguchi; Hideki Sakai
Journal:  J Physiol Sci       Date:  2011-09-20       Impact factor: 2.781

2.  A quantitative and qualitative RNA expression profiling assay for cell culture with single cell resolution.

Authors:  Petra Kraus; Rachel Yerden; Darren Sipes; Shantanu Sur; Thomas Lufkin
Journal:  Cytotechnology       Date:  2017-08-10       Impact factor: 2.058

3.  2-Benzylidenebenzofuran-3(2H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies.

Authors:  Jamshaid Ashraf; Ehsan Ullah Mughal; Reem I Alsantali; Amina Sadiq; Rabab S Jassas; Nafeesa Naeem; Zaman Ashraf; Yasir Nazir; Muhammad Naveed Zafar; Amara Mumtaz; Masoud Mirzaei; Satar Saberi; Saleh A Ahmed
Journal:  RSC Adv       Date:  2021-10-29       Impact factor: 4.036

Review 4.  Assay format as a critical success factor for identification of novel inhibitor chemotypes of tissue-nonspecific alkaline phosphatase from high-throughput screening.

Authors:  Thomas D Y Chung; Eduard Sergienko; José Luis Millán
Journal:  Molecules       Date:  2010-04-27       Impact factor: 4.411

5.  Direct determination of phosphatase activity from physiological substrates in cells.

Authors:  Zhongyuan Ren; Le Duy Do; Géraldine Bechkoff; Saida Mebarek; Nermin Keloglu; Saandia Ahamada; Saurabh Meena; David Magne; Slawomir Pikula; Yuqing Wu; René Buchet
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 6.  Obesity, Diabetes Mellitus, and Vascular Impediment as Consequences of Excess Processed Food Consumption.

Authors:  Susmita Sinha; Mainul Haque
Journal:  Cureus       Date:  2022-09-04

7.  Understanding the enzymatic inhibition of intestinal alkaline phosphatase by aminophenazone-derived aryl thioureas with aided computational molecular dynamics simulations: synthesis, characterization, SAR and kinetic profiling.

Authors:  Asma Khurshid; Aamer Saeed; Zaman Ashraf; Qamar Abbas; Mubashir Hassan
Journal:  Mol Divers       Date:  2020-08-29       Impact factor: 2.943

8.  Interactive roles of CD73 and tissue nonspecific alkaline phosphatase in the renal vascular metabolism of 5'-AMP.

Authors:  Edwin K Jackson; Dongmei Cheng; Jonathan D Verrier; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-02

9.  Tricyclic coumarin sulphonate derivatives with alkaline phosphatase inhibitory effects: in vitro and docking studies.

Authors:  Jamshed Iqbal; Mohammed I El-Gamal; Syeda Abida Ejaz; Joanna Lecka; Jean Sévigny; Chang-Hyun Oh
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

10.  Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.

Authors:  Tina Kiffer-Moreira; Manisha C Yadav; Dongxing Zhu; Sonoko Narisawa; Campbell Sheen; Boguslaw Stec; Nicholas D Cosford; Russell Dahl; Colin Farquharson; Marc F Hoylaerts; Vicky E Macrae; José Luis Millán
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.